isabelobrien, Author at European Medical Journal - Page 52 of 68

Cancer treatment collaboration announced

Queen’s University Belfast has entered into a collaboration and licensing agreement with Ipsen to research, develop, manufacture and commercialise FLIP inhibitors.

Ripples of change in R&D

How can pharma companies improve inclusivity across their R&D cycles?

The biotech boom: fad or forever?

Biotechs have stood as agile hubs for drug discovery, but now they are being coveted by investors.

Standing out in a crowd of digital content

The amount of digital content being created for healthcare professionals has grown exponentially. Medical affairs teams must find a way to cut through the noise with their communications

A cautionary tale of digital transformation

As the pharmaceutical industry embraces digital transformation, new technologies have the potential to sink or swim. How can the industry ensure it’s backing the most effective innovations and not getting stuck in dead ends?

The future of pharmaceutical sales

The COVID-19 pandemic has reshaped pharmaceutical sales, moving from face-to-face to predominantly digital interactions. How can sales reps adapt to multichannel approaches and enhance performance amidst this shift in sales training and team dynamics?

In data we trust: how to nail consent and preference management

The pharmaceutical industry’s digital transformation during the pandemic has fuelled fresh opportunities to collect and harness data, but this venture must be approached with a strong consideration for consent and preference management rules

Amgen's Tamika Jean-Baptiste on creating an equitable experience

An interview with Tamika-Jean Baptiste, Vice President and Chief Diversity Officer, Amgen.

The value of purpose

The corporate environment is evolving, and ‘purpose’ is more important than ever to young recruits looking for their next role. We examine how the pharmaceutical industry is embracing the importance of purpose for retention, reputation, and brand differentiation

Sustainable solutions for a greener tomorrow

From drug development to disposal, how can all processes and functions be considered through a greener lens, and work towards a healthier and safer future?